降糖明目汤对BDR大鼠的抵抗素与NF-κB影响的实验研究  被引量:2

Experimental Study of Jiangtangmingmu Formula to BDR model Rabbits'Resistin and NF-κB

在线阅读下载全文

作  者:纪云西[1] 蒋历[2] 宋春晖[2] 吴大力[3] 易志彪[1] 陈大舜[2] 

机构地区:[1]广州中医药大学,广东广州510405 [2]湖南中医药大学,湖南长沙410007 [3]广西中医学院,广西南宁530001

出  处:《辽宁中医杂志》2010年第9期1818-1820,共3页Liaoning Journal of Traditional Chinese Medicine

摘  要:目的:观察降糖明目汤对背景期糖尿病视网膜病变(BDR)模型兔的抵抗素、NF-κB的影响。方法:BDR模型兔随机分为模型组、降糖明目汤治疗组和西药导升明对照组,检测血清抵抗素、胰腺组织NF-κBp65表达,并与正常组比较。结果:模型组实验兔血清抵抗素浓度明显升高,与中药治疗组、西药对照组和空白对照组三者比较有极显著性差异(P<0.01);但中药治疗组、西药对照组和空白对照组三者之间比较均无显著性差异(P>0.05)。模型组实验兔胰腺组织NF-κBp65强表达,与正常组、中药治疗组比较,有极显著差异(P<0.01),与西药对照组比较无显著性差异(P>0.05);中药治疗组与西药对照组比较有显著性差异(P<0.05)。中药治疗组与正常组比较无显著性差异(P>0.05)。结论:中药降糖明目汤具有一定的抑制NF-κBp65的表达,降低血清抵抗素浓度的作用。Objective:To observe the effect of jiangtangmingmu formula to BDR model Rabbits'Resistin and NF-κB p65. Methods:BDR model Rabbits were randomly divided into jiangtang -mingmu formula group,western medicine Doxium group and model group,detecting serum Resistin,the expression of NF-κB p65 in pancreatic gland,and compared with normal group's. Results:The density of serum Resistin of model group obviously increases and there is obviously significance compared with the other three groups( P 0. 01) ,but there no significance among control group and western medicine group,normal group( P 0. 05). there is high expression of NF-κB p65 in pancreatic gland of model group,and statistic significance compared with control group and normal group( P 0. 01) ,but no significance with western medicine group( P 0. 05). there is statistic significance between control group and western medicine group( P 0. 05) ,and no significance with between control group and normal group( P 0. 05). Conclusion:Jiangtang-mingmu formula can inhibit expression of NF-κB p65 and lower down the density of serum Resistin.

关 键 词:降糖明目汤 背景期糖尿病视网膜病变 抵抗素 NF-ΚB 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象